Viewing data from:

WARFARIN SODIUM

ANDA

WARFARIN SODIUM | A090935 | INVAGEN PHARMACEUTICALS INC

9 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 16 NDCs

Highest NADAC/Unit

$0.1041

per ea

Lowest NADAC/Unit

$0.0784

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
76282033301WARFARIN SODIUM 6 MG TABLET	$0.1041	EA	Generic	—	2026-06-17
76282033310WARFARIN SODIUM 6 MG TABLET	$0.1041	EA	Generic	—	2026-06-17
76282033501WARFARIN SODIUM 10 MG TABLET	$0.1010	EA	Generic	—	2026-06-17
76282033101WARFARIN SODIUM 4 MG TABLET	$0.0954	EA	Generic	—	2026-06-17
76282033110WARFARIN SODIUM 4 MG TABLET	$0.0954	EA	Generic	—	2026-06-17
76282033010WARFARIN SODIUM 3 MG TABLET	$0.0896	EA	Generic	—	2026-06-17

Showing 6 of 16 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 16 NDCs (16 FSS)

Lowest Price

$21.87

Highest Price

$274.03

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
76282-0327-01WARFARIN NA (EXELAN) 1MG TAB	$21.87	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0327-10WARFARIN NA (EXELAN) 1MG TAB	$218.74	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0328-01WARFARIN NA (EXELAN) 2MG TAB	$21.87	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0328-10WARFARIN NA (EXELAN) 2MG TAB	$218.74	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0329-01WARFARIN NA (EXELAN) 2.5MG TAB	$21.87	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026
76282-0329-10WARFARIN NA (EXELAN) 2.5MG TAB	$218.74	FSS	Exelan Pharmaceuticals, Inc.	09/14/2026

Showing 6 of 16 NDCs.

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain12 active DMFs9 inactive

10 active API suppliers hold Drug Master Files for this ingredient.

APOTEX INCWARFARIN SODIUM CLATHRATE USP

DMF 113871995

TAPI NL BVWARFARIN SODIUM CLATHRATE

DMF 122691996

TARO PHARMACEUTICAL INDUSTRIES LTDWARFARIN SODIUM CLATHRATE USP

DMF 127461997

ZYDUS LIFESCIENCES LTDWARFARIN SODIUM USP (CRYSTALLINE CLATHRATE)

DMF 129771998

IPCA LABORATORIES LTDWARFARIN SODIUM CLATHRATE USP

DMF 216802008

CHIERON ACTIVE INGREDIENTS PRIVATE LTDWARFARIN SODIUM USP (AMORPHOUS)

DMF 219252008

FARMAK ASWARFARIN SODIUM

DMF 221322008

ALCHYMARS ICM SM PRIVATE LTDWARFARIN SODIUM USP

DMF 222992008

RAKS PHARMA PVT LTDWARFARIN SODIUM CLATHRATE USP

DMF 232892009

ALEMBIC PHARMACEUTICALS LTDWARFARIN SODIUM AMORPHOUS USP

DMF 247122011

ALEMBIC PHARMACEUTICALS LTDWARFARIN SODIUM CLATHRATE USP

DMF 247962011

CHIERON ACTIVE INGREDIENTS PRIVATE LTDWARFARIN SODIUM CLATHRATE

DMF 364062021

BRISTOL MYERS SQUIBB COInactiveWARFARIN SODIUM USP

DMF 24671975

MEDEA RESEARCH LABORATORIES INCInactiveWARFARIN SODIUM

DMF 105301993

NAPP TECHNOLOGIES INCInactiveWARFARIN SODIUM CLATHRATE

DMF 121171996

SHANGHAI SHEN XING PHARMACEUTICAL FACTORYInactiveWARFARIN SODIUM, USP

DMF 127041997

ASPEN OSS BVInactiveWARFARIN SODIUM

DMF 143991999

NUTRA SPECIALITIES PRIVATE LTDInactiveWARFARIN SODIUM USP (CLATHRATE)

DMF 219262008

IPCA LABORATORIES LTDInactiveWARFARIN SODIUM USP

DMF 222152009

QILU ANTIBIOTICS LINYI PHARMACEUTICAL CO LTDInactiveWARFARIN SODIUM (NON-STERILE, API)

DMF 262682012

UNICHEM LABORATORIES LTDInactiveWARFARIN SODIUM USP

DMF 289252014

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.